THERACLION (ALTHE.PA) Stock Price, Forecast & Analysis
Europe - EPA:ALTHE - FR0010120402 - Common Stock
ALTHE.PA Key Statistics, Chart & Performance
The current stock price of ALTHE.PA is 0.74 EUR. In the past month the price increased by 8.82%. In the past year, price increased by 97.33%.
ALTHE.PA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABL.DE | ABBOTT LABORATORIES | 25.18 | 190.16B | ||
| IUI1.DE | INTUITIVE SURGICAL INC | 62.44 | 167.64B | ||
| 1ISRG.MI | INTUITIVE SURGICAL INC | 61.6 | 165.38B | ||
| BSX.DE | BOSTON SCIENTIFIC CORP | 33.46 | 127.43B | ||
| 2M6.DE | MEDTRONIC PLC | 16.3 | 100.56B | ||
| SHL.DE | SIEMENS HEALTHINEERS AG | 18.88 | 50.68B | ||
| 1BDX.MI | BECTON DICKINSON AND CO | 12.62 | 44.91B | ||
| BOX.DE | BECTON DICKINSON AND CO | 12.48 | 44.44B | ||
| EWL.DE | EDWARDS LIFESCIENCES CORP | 32.77 | 43.10B | ||
| PHIA.AS | KONINKLIJKE PHILIPS NV | 17 | 23.57B | ||
| PHI1.DE | KONINKLIJKE PHILIPS NV | 17.02 | 23.60B | ||
| DC4.DE | DEXCOM INC | 32.61 | 20.72B |
Related stock screener links
About ALTHE.PA
Company Profile
Théraclion SA develops, manufactures, and markets oncological medical equipment. The company is headquartered in Malakoff, Ile-De-France and currently employs 32 full-time employees. The company went IPO on 2014-04-25. The firm is a a spin-off of Inserm and EDAPTechomed. The main activity of the Company is developping, manufacturing and marketing echotherapy medical equipments associating therapy by focused ultrasound and monitoring by ultrasound. The firm provides Echopulse, a device for the non-invasive and outpatient treatment of the fibroadenoma of the breast and thyroid nodules.
Company Info
THERACLION
244, avenue Pierre Brossolette
Malakoff ILE-DE-FRANCE FR
Employees: 28
Phone: 33155489070
THERACLION / ALTHE.PA FAQ
What does ALTHE do?
Théraclion SA develops, manufactures, and markets oncological medical equipment. The company is headquartered in Malakoff, Ile-De-France and currently employs 32 full-time employees. The company went IPO on 2014-04-25. The firm is a a spin-off of Inserm and EDAPTechomed. The main activity of the Company is developping, manufacturing and marketing echotherapy medical equipments associating therapy by focused ultrasound and monitoring by ultrasound. The firm provides Echopulse, a device for the non-invasive and outpatient treatment of the fibroadenoma of the breast and thyroid nodules.
Can you provide the latest stock price for THERACLION?
The current stock price of ALTHE.PA is 0.74 EUR. The price increased by 13.85% in the last trading session.
Does ALTHE stock pay dividends?
ALTHE.PA does not pay a dividend.
What is the ChartMill rating of THERACLION stock?
ALTHE.PA has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
What sector and industry does THERACLION belong to?
THERACLION (ALTHE.PA) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
How is the valuation of THERACLION (ALTHE.PA) based on its PE ratio?
THERACLION (ALTHE.PA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.12).
ALTHE.PA Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to ALTHE.PA. When comparing the yearly performance of all stocks, ALTHE.PA is one of the better performing stocks in the market, outperforming 97.1% of all stocks.
ALTHE.PA Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to ALTHE.PA. Both the profitability and financial health of ALTHE.PA have multiple concerns.
ALTHE.PA Financial Highlights
Over the last trailing twelve months ALTHE.PA reported a non-GAAP Earnings per Share(EPS) of -0.12. The EPS decreased by -53.33% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -50.21% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |